Galmed Pharmaceuticals Ltd.
GLMD
$1.07
$0.1111.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.70M | -8.72M | -7.35M | -7.52M | -6.32M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 74.00K | 83.00K | 89.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.53M | 2.62M | 2.15M | 2.22M | 513.00K |
| Change in Net Operating Assets | -165.00K | 569.00K | -151.00K | -728.00K | 852.00K |
| Cash from Operations | -6.34M | -5.53M | -5.28M | -5.94M | -4.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.35M | -8.84M | -2.87M | -2.21M | 3.62M |
| Cash from Investing | -8.35M | -8.84M | -2.87M | -2.21M | 3.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.29M | 16.34M | 10.30M | 8.79M | 8.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.29M | 16.34M | 10.30M | 8.79M | 8.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.41M | 1.97M | 2.15M | 634.00K | 7.09M |